Avalon Pharma board nods to 7.5% cash dividend for H1 2024

30/07/2024 Argaam Exclusive

Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) board of directors agreed on the distribution of a 7.5% cash dividend, at SAR 0.75 per share, for H1 2024, the company said in a statement to Tadawul

 

Dividend Details (H1 2024)

Capital

SAR 200.00 mln

Number of Shares

20.00 mln

Total Dividend  

SAR 15.00 mln

Percentage of Capital

7.5% (SAR 0.75 per share)

Record Date  

Sept. 1, 2024

Payment Date

Sept. 15, 2024

 

According to data available to Argaam, this will be the first dividend distribution for the company after being listed on TASI last February.

Dividend History (SAR/share) Corporate Actions

Announcement Ex-Dividend Payment Dividends
(M Riyal)
Dividends * Notes
30/07/2024 01/09/2024 15/09/2024 15.00 0.75
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any

Dividend History

Consolidated cash dividend Cash dividend per share (SAR) * The stock price at the beginning of the period (SAR) Return on the base price
Last 3 Financial years N/A N/A N/A
Last 5 Financial years N/A N/A N/A
Last 10 Financial years N/A N/A N/A
Based on the beginning of the period (January 1 of the base year)

Historical Dividends

ajax loading

Valuation Data (Latest Share Price)

P/E (TTM) 33.66
P/E Before Unusual Items (TTM) 33.66
P/BV 8.08
Dividend Yield -
Market Cap. (M) 2,548.00
Return on Average Assets -
Return on Average Equity 25.85 %

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.